The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia

Beyond Cholesterol

Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

Schafer, F. Q., & Buettner, G. R. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00480-4 · Cited by 4,587

Clinical epidemiology of cardiovascular disease in chronic renal disease

Rn, F., Parfrey, P. S., & Sarnak, M. J. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,960

The Lipid Research Clinics Coronary Primary Prevention Trial Results: I. Reduction in Incidence of Coronary Heart Disease

(1984) · JAMA · doi:10.1001/jama.1984.03340270029025 · Cited by 2,747

The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease

Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328

Dietary Protein Intake and the Progressive Nature of Kidney Disease:

Epstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,067

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

Witko‐Sarsat, V., Friedlander, M. A., Capeillère‐Blandin, C., Nguyen‐Khoa, T., Nguyen, A., Zingraff, J., Jungers, P., & Descamps‐Latscha, B. (1996) · Kidney International · doi:10.1038/ki.1996.186 · Cited by 2,000

Death Risk in Hemodialysis Patients: The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between Facilities

Lowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,965

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

Stenvinkel, P., Heimbürger, O., Paultre, F., Diczfalusy, U., Wang, T., Berglund, L., & Jogestrand, T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00422.x · Cited by 1,767

Total and corrected antioxidant capacity in hemodialyzed patients

Malliaraki, N. E., Mpliamplias, D., Kampa, M., Perakis, K., Margioris, A. N., & Castanas, E. (2003) · BMC Nephrology · doi:10.1186/1471-2369-4-4 · Cited by 41

Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?

Vaziri, N. D. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0847 · Cited by 40

Lipoperoxidation and hemodialysis

Ramos, R., & Martínez‐Castelao, A. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.004 · Cited by 41

Interrelationship Between Uremic Toxicity and Oxidative Stress

Rutkowski, P., Małgorzewicz, S., Slominska, E. M., Renke, M., Łysiak−Szydłowska, W., Świerczyński, J., & Rutkowski, B. (2006) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2006.04.008 · Cited by 41

Blood enzymes and oxidative stress in chronic kidney disease: a cross sectional study.

Johnson‐Davis, K. L., Fernelius, C. A., Eliason, N. B., Wilson, A. R., Beddhu, S., & Roberts, W. L. (2011) · PubMed · Cited by 40

Klotho ameliorates cyclosporine A–induced nephropathy via PDLIM2/NF-kB p65 signaling pathway

Jin, M., Lv, P., Chen, G., Wang, P., Zuo, Z., Ren, L., Bi, J., Yang, C. W., Mei, X., & Han, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.061 · Cited by 40

A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders

Roberts, P. R., Stromberg, K. D., Johnson, L. C., Wiles, B. M., Mavrakanas, T. A., & Charytan, D. M. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2020.10.020 · Cited by 40

Cruciferous vegetables: rationale for exploring potential salutary effects of sulforaphane-rich foods in patients with chronic kidney disease

Cardozo, L., Alvarenga, L., Ribeiro, M. M., Dai, L., Shiels, P. G., Stenvinkel, P., Lindholm, B., & Mafra, D. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa129 · Cited by 42

Oxidative Stress in Patients with End-Stage Renal Disease prior to the Start of Renal Replacement Therapy

Diepeveen, S. H. A., Verhoeven, G. H. W. E., van der Palen, J. A. M., Dikkeschei, B. D., van Tits, L. J., Kolsters, G., Offerman, J. J. G., Bilo, H. J. G., & Stalenhoef, A. F. H. (2004) · Nephron Clinical Practice · doi:10.1159/000079921 · Cited by 40

Advanced Oxidation Protein Products Induce Vascular Calcification by Promoting Osteoblastic Trans-Differentiation of Smooth Muscle Cells via Oxidative Stress and ERK Pathway

You, H., Yang, H., Zhu, Q., Li, M., Xue, J., Gu, Y., Lin, S., & Ding, F. H. (2009) · Renal Failure · doi:10.1080/08860220902875182 · Cited by 40

The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies

Miceli, G., Basso, M. G., Rizzo, G., Pintus, C., & Tuttolomondo, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314914 · Cited by 42

Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice

Yu, J., Deng, M., Zhao, J., & Huang, L. J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.046 · Cited by 39

Oxidized LDL to autoantibodies against oxLDL ratio – The new biomarker associated with carotid atherosclerosis and cardiovascular complications in dialyzed patients

Pawlak, K., Myśliwiec, M., & Pawlak, D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.07.011 · Cited by 39

Interleukin-6 Is a Better Predictor of Mortality as Compared to C-Reactive Protein, Homocysteine, Pentosidine and Advanced Oxidation Protein Products in Hemodialysis Patients

Pachaly, M. A., do Nascimento, M. M., Suliman, M. E., Hayashi, S. Y., RIELLA, M. C., Manfro, R. C., Stenvinkel, P., & Lindholm, B. (2008) · Blood Purification · doi:10.1159/000117438 · Cited by 39

Niacin and Progression of CKD

Streja, E., Kovesdy, C. P., Streja, D. A., Moradi, H., Kalantar‐Zadeh, K., & Kashyap, M. L. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.11.033 · Cited by 39

Oxidative modifications impair albumin quantification

Michelis, R., Kristal, B., Snitkovsky, T., & Sela, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.09.027 · Cited by 39

Causes and consequences of inflammation on anemia management in hemodialysis patients

Chawla, L. S., & Krishnan, M. (2009) · Hemodialysis International · doi:10.1111/j.1542-4758.2009.00352.x · Cited by 38

Hemodialysis Central Venous Catheters as a Source of Inflammation and Its Implications

Hung, A. M., & Ikizler, T. A. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00444.x · Cited by 40

Effect of N-Acetylcysteine on Endothelial Dysfunction in Dialysis Patients

Şahin, G., Yalcin, A. U., & Akçar, N. (2007) · Blood Purification · doi:10.1159/000106103 · Cited by 39

N-Acetylcysteine in nephrology; contrast nephropathy and beyond

Tepel, M., & Zidek, W. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200411000-00011 · Cited by 39

Causal effects of systemic inflammatory regulators on chronic kidney diseases and renal function: a bidirectional Mendelian randomization study

Li, H., Li, M., Liu, C., He, P., Dong, A., Dong, S., & Zhang, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229636 · Cited by 40

Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD)

Pahl, M. V., Ni, Z., Sepassi, L., Moradi, H., & Vaziri, N. D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp120 · Cited by 38

Considerations in Starting a Patient with Advanced Frailty on Dialysis

Swidler, M. A. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12121112 · Cited by 38

Paraoxonase Enzyme Activity Is Enhanced by Zinc Supplementation in Hemodialysis Patients

Rahimi-Ardabili, B., Argani, H., Ghorbanihaghjo, A., Rashtchizadeh, N., Naghavi‐Behzad, M., Ghorashi, S., & Nezami, N. (2012) · Renal Failure · doi:10.3109/0886022x.2012.717479 · Cited by 38

Aging and uremia: Is there cellular and molecular crossover?

White, W. E. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i1.19 · Cited by 38

Light wine consumption is associated with a lower odd for cardiovascular disease in chronic kidney disease

Jespersen, T., Kruse, N. T., Mehta, T. H., Kuwabara, M., Noureddine, L. A., & Jalal, D. I. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.06.018 · Cited by 38

Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/RAGE axis in a chronic renal failure rat model

Wang, C., Lee, A., Liu, S., Chang, K., Shen, M., & Chang, C. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1534-4 · Cited by 38

Intersection Between Chronic Kidney Disease and Cardiovascular Disease

Laffin, L. J., & Bakris, G. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01546-8 · Cited by 44

Determination of N-Acetylcysteine and Main Endogenous Thiols in Human Plasma by HPLC with Ultraviolet Detection in the Form of Their S-Quinolinium Derivatives

Głowacki, R., & Bald, E. (2009) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826070903249666 · Cited by 38

Coenzyme Q10 Administration Suppresses both Oxidative and Antioxidative Markers in Hemodialysis Patients

Sakata, T., Furuya, R., Shimazu, T., Odamaki, M., Ohkawa, S., & Kumagai, H. (2008) · Blood Purification · doi:10.1159/000135605 · Cited by 37

Abdominal aortic calcification score can predict future coronary artery disease in hemodialysis patients: a 5-year prospective cohort study

Chen, H.-C., Wang, W., Hsi, C.-N., Chou, C., Lin, H., Huang, C., & Chang, C. (2018) · BMC Nephrology · doi:10.1186/s12882-018-1124-x · Cited by 38

Allometric Trophic Networks From Individuals to Socio-Ecosystems: Consumer–Resource Theory of the Ecological Elephant in the Room

Martinez, N. D. (2020) · Frontiers in Ecology and Evolution · doi:10.3389/fevo.2020.00092 · Cited by 36

Systematic review of the nuclear factor erythroid 2-related factor 2 (NRF2) system in human chronic kidney disease: alterations, interventions and relation to morbidity

Juul-Nielsen, C., Shen, J., Stenvinkel, P., & Scholze, A. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab031 · Cited by 37

Differential Expression of Proteins From Cultured Endothelial Cells Exposed to Uremic Versus Normal Serum

Carbó, C., Arderiu, G., Escolar, G., Fusté, B., Cases, A., Carrascal, M., Abián, J., & Díaz‐Ricart, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.11.029 · Cited by 38

Salt: Its Role in Chronic Kidney Disease

Thijssen, S., Kitzler, T. M., & Levin, N. W. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.10.006 · Cited by 37

Dialysis-related systemic microinflammation is associated with specific genomic patterns

Zaza, G., Pontrelli, P., Pertosa, G. B., Granata, S., Rossini, M., Porreca, S., Staal, F. J. T., Gesualdo, L., Grandaliano, G., & Schena, F. P. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm804 · Cited by 39

Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?

Göçmen, A. Y., Şahın, E., Semiz, E., & Gümüşlü, S. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70586-5 · Cited by 36

Association between Markers of Inflammation, Fibrosis and Hypervolemia in Peritoneal Dialysis Patients

Gangji, A. S., Brimble, K. S., & Margetts, P. J. (2009) · Blood Purification · doi:10.1159/000232937 · Cited by 36

Preventive Effect of a Proteasome Inhibitor on the Formation of Accelerated Atherosclerosis in Rabbits With Uremia

Feng, B., Zhang, Y., Mu, J., Ye, Z., Zeng, W., Qi, W., Luo, Z., Guo, Y., Xu, Y., & Yuan, F. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181c87f8e · Cited by 35

Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor- in visceral adipocytes

Aminzadeh, M. A., Pahl, M. V., Barton, C. H., Doctor, N. S., & Vaziri, N. D. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp405 · Cited by 36

Positive Acute-Phase Inflammatory Markers in Different Stages of Chronic Kidney Disease

Romão, J. E., Haiashi, A. R., Elias¹, R. M., Luders, C., Ferraboli, R., Castro, M. C. M., & Abensur, H. (2006) · American Journal of Nephrology · doi:10.1159/000091806 · Cited by 36

Effect of a hydrogen ( H2 )‐enriched solution on the albumin redox of hemodialysis patients

Terawaki, H., Zhu, W., Matsuyama, Y., Terada, T., Takahashi, Y., Sakurai, K., Kabayama, S., Miyazaki, M., Itami, N., Nakazawa, R., et al. (2013) · Hemodialysis International · doi:10.1111/hdi.12112 · Cited by 35

Chronic kidney disease measures for cardiovascular risk prediction

Mok, Y., Ballew, S. H., & Matsushita, K. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.007 · Cited by 37

Inflammation and Subclinical Infection in Chronic Kidney Disease: A Molecular Approach

Cazzavillan, S., Ratanarat, R., Segala, C., Corradi, V., de Cal, M., Cruz, D., Ocampo, C., Polanco, N., Rassu, M., Levin, N. W., et al. (2006) · Blood Purification · doi:10.1159/000096401 · Cited by 35

Effect of Chronic Antioxidant Therapy with Superoxide Dismutase-Mimetic Drug, Tempol, on Progression of Renal Disease in Rats with Renal Mass Reduction

Quiroz, Y., Ferrebuz, A., Vaziri, N. D., & Rodríguez‐Iturbe, B. (2009) · Nephron Experimental Nephrology · doi:10.1159/000210577 · Cited by 35

Influence of renal compensatory hypertrophy on mitochondrial energetics and redox status

Benipal, B., & Lash, L. H. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.10.010 · Cited by 35

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Charytan, D. M., Lewis, E. F., Desai, A. S., Weinrauch, L. A., Ivanovich, P. T., Toto, R. D., Claggett, B. L., Liu, J., Hartley, L. H., Finn, P. V., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.02.324 · Cited by 35

Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease—impact on plasma adiponectin concentration

Barazzoni, R., Bernardi, A., Biasia, F., Semolic, A., Bosutti, A., Mucci, M., Dore, F., Zanetti, M., & Guarnieri, G. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00745.2006 · Cited by 35

UNRESOLVED ISSUES IN DIALYSIS: Extracorporeal Strategies for the Removal of Middle Molecules

Winchester, J. F., & Audia, P. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00135.x · Cited by 35

Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study

Tumlin, J. A., Roy‐Chaudhury, P., Koplan, B. A., Costea, A., Kher, V., Williamson, D. E., Pokhariyal, S., & Charytan, D. M. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1212-6 · Cited by 34

Cardiovascular Disease in Patients With Chronic Kidney Disease

Jaradat, M. I., & Molitoris, B. A. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.35964 · Cited by 34

Serum Vitamin E and Oxidative Protein Modification in Hemodialysis: A Randomized Clinical Trial

Lu, L., Erhard, P., Salomon, R. G., & Weiss, M. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.001 · Cited by 34

Effects of lowering dialysate sodium on flow-mediated dilatation in patients with chronic kidney disease

Kutlugün, A. A., Erdem, Y., Okutucu, S., Yorgun, H., Atalar, E., & Arıcı, M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr092 · Cited by 34

Cardiovascular Disease in Patients with Chronic Kidney Disease

Weiner, D. E., & Sarnak, M. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00010-8 · Cited by 35

Iron and Oxidative Stress in Renal Insufficiency

Lim, C. S., & Vaziri, N. D. (2004) · American Journal of Nephrology · doi:10.1159/000082201 · Cited by 34

The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs

Nogueira, J. M., & Weir, M. R. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04131206 · Cited by 34

High glucose-induced senescence contributes to tubular epithelial cell damage in diabetic nephropathy

Xu, D., Moru, P., Liao, K., Song, W., Yang, P., Zang, D., Cai, C., & Zhou, H. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112609 · Cited by 38

Regulatory circuits controlling vascular cell calcification

Sallam, T., Cheng, H., Demer, L. L., & Tintut, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1231-y · Cited by 34

L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats

Taşkın, E. (2014) · Medical Science Monitor · doi:10.12659/msm.890528 · Cited by 33

A review on the efficacy and mechanism of action of Shenkang injection against chronic kidney disease

Zou, J., Zhou, X., Chen, Y.-K., Liu, J.-L., Wang, C., Ma, Y., & Wang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110833 · Cited by 33

Salutary Effects of Hemodialysis on Low-Density Lipoprotein Proinflammatory and High-Density Lipoprotein Anti-inflammatory Properties in Patient With End-Stage Renal Disease

Vaziri, N. D., Navab, K. D., Gollapudi, P., Moradi, H., Pahl, M. V., Barton, C. H., Fogelman, A. M., & Navab, M. (2011) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30368-0 · Cited by 33

Inflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study

Nerpin, E., Helmersson‐Karlqvist, J., Risérus, U., Sundström, J., Larsson, A. O., Jobs, E. N., Basu, S., Ingelsson, E., & Ärnlöv, J. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-537 · Cited by 33

Coronary Artery Calcification, Systemic Inflammation Markers and Mineral Metabolism in a Peritoneal Dialysis Population

Ammirati, A. L., Dalboni, M. A., Cendoroglo, M. N., Draibe, S. A., & Canziani, M. E. F. (2006) · Nephron Clinical Practice · doi:10.1159/000093257 · Cited by 33

Keratin 18 and Heat-Shock Protein in Chronic Kidney Disease

Lebherz-Eichinger, D., Krenn, C. G., & Roth, G. A. (2013) · Advances in clinical chemistry · doi:10.1016/b978-0-12-800096-0.00003-2 · Cited by 33

Measurement of the intestinal permeability in chronic kidney disease

Terpstra, M. L., Singh, R., Geerlings, S. E., & Bemelman, F. J. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i4.378 · Cited by 32

Impaired resistance artery function in patients with end-stage renal disease

Luksha, N., Luksha, L., Carrero, J. J., Hammarqvist, F., Stenvinkel, P., & Kublickiene, K. R. (2011) · Clinical Science · doi:10.1042/cs20100277 · Cited by 33

DNA damage in salivary gland tissue in patients with chronic kidney disease, measured by the comet assay

Ersson, C., Thorman, R., Rodhe, Y., Möller, L., & Hylander, B. (2011) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2011.03.016 · Cited by 32

Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients

Pawlak, K., Pawlak, D., & Myśliwiec, M. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.01.011 · Cited by 32

Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice

Bro, S., Binder, C. J., Witztum, J. L., Ølgaard, K., & Nielsen, L. B. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.139634 · Cited by 32

Low Glomerular Filtration Rate, Recurrent Stroke Risk, and Effect of Renin–Angiotensin System Modulation

Ovbiagele, B., Bath, P. M., Cotton, D., Sha, N., & Diener, H. (2013) · Stroke · doi:10.1161/strokeaha.113.002463 · Cited by 32

Non-mercaptalbumin, Oxidized Form of Serum Albumin, Significantly Associated with Renal Function and Anemia in Chronic Kidney Disease Patients

Nakatani, S., Yasukawa, K., Ishimura, E., Nakatani, A., Toi, N., Uedono, H., Tsuda, A., Yamada, S., Ikeda, H., Mori, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35177-x · Cited by 32

Carbamylated LDL

Basnakian, A. G., Shah, S. V., Ok, E., Altunel, E., & Apostolov, E. O. (2010) · Advances in clinical chemistry · doi:10.1016/s0065-2423(10)51002-3 · Cited by 33

Folic acid and Vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients

Assanelli, D., Bonanome, A., Pezzini, A., Albertini, F., Maccalli, P., Grassi, M., Archetti, S., Negrini, R., & Visioli, F. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.07.009 · Cited by 32

Vascular access and cardiac disease: is there a relationship?

MacRae, J. M. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000247506.79538.3e · Cited by 32

Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: an exploratory study

Chung, A. W. Y., Yang, H. H. C., Kim, J. M., Sigrist, M. K., Brin, G., Chum, E., Gourlay, W. A., & Levin, A. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq202 · Cited by 32

Statins in chronic kidney disease and kidney transplantation

Kassimatis, T. I., & Goldsmith, D. J. A. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.011 · Cited by 32

A Pilot Randomized Crossover Trial Assessing the Safety and Short-Term Effects of Pomegranate Supplementation in Hemodialysis Patients

Rivara, M. B., Mehrotra, R., Linke, L., RUZINSKI, J. T., Ikizler, T. A., & Himmelfarb, J. (2014) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2014.07.006 · Cited by 31

The value of the Brazilian açai fruit as a therapeutic nutritional strategy for chronic kidney disease patients

Martins, I. C. V. S., Borges, N. A., Stenvinkel, P., Lindholm, B., Rogez, H. L. G., Pinheiro, M. C. N., do Nascimento, J. L. M., & Mafra, D. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1912-z · Cited by 31

Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine

Wiesenhofer, F. M., Herzog, R., Boehm, M., Wagner, A., Unterwurzacher, M., Kasper, D. C., Alper, S. L., Vychytil, A., Aufricht, C., & Kratochwill, K. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01961 · Cited by 30

Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress

Wang, Y., Pang, L., Zhang, Y., Lin, J., & Zhou, H. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8936856 · Cited by 32

Oxidative Status before and after Renal Replacement Therapy: Differences between Conventional High Flux Hemodialysis and on-Line Hemodiafiltration

Navarro‐García, J. A., Rodríguez‐Sánchez, E., Aceves‐Ripoll, J., Abarca‐Zabalía, J., Susmozas-Sánchez, A., González‐Lafuente, L., Bada-Bosch, T., Hernández, E., Mérida-Herrero, E., Praga, M., et al. (2019) · Nutrients · doi:10.3390/nu11112809 · Cited by 31

Dyslipidemia in Dialysis Patients

Qunibi, W. Y. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12375 · Cited by 32

Vitamin E–coated polysulfone membrane improved red blood cell antioxidant status in hemodialysis patients

Bargnoux, A., Cristol, J., Jaussent, I., Chalabi, L., Bories, P., Dion, J.-J., Henri, P., Delage, M., Dupuy, A., Badiou, S., et al. (2012) · Journal of Nephrology · doi:10.5301/jn.5000195 · Cited by 31

Protecting the endothelium: A new focus for management of chronic kidney disease

Díaz-Buxó, J. A., & Woods, H. F. (2006) · Hemodialysis International · doi:10.1111/j.1542-4758.2006.01173.x · Cited by 31

Oxidative stress: An essential factor in the process of arteriovenous fistula failure

Hu, K., Guo, Y., Li, Y., Lu, C., Cai, C., Zhou, S., Ke, Z., Li, Y., & Wang, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.984472 · Cited by 33

HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Intravenous Iron Therapy in End‐Stage Renal Disease

Brewster, U. C. (2006) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2006.00174.x · Cited by 30

Iatrogenic iron overload and its potential consequences in patients on hemodialysis

Rostoker, G., & Vaziri, N. D. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.014 · Cited by 30

Uremic Advanced Glycation End Products and Protein‐Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel‐Like Factor 2

Saum, K. L., Campos, B., Celdran‐Bonafonte, D., Nayak, L. V., Sangwung, P., Thakar, C. V., Roy‐Chaudhury, P., & Owens, A. P. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007566 · Cited by 30

Plasma Protein Carbonyls as Biomarkers of Oxidative Stress in Chronic Kidney Disease, Dialysis, and Transplantation

Colombo, G., Reggiani, F., Angelini, C., Finazzi, S., Astori, E., Garavaglia, M. L., Landoni, L., Portinaro, N. M., Giustarini, D., Rossi, R., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2975256 · Cited by 30

Macrophage and adipocyte interaction as a source of inflammation in kidney disease

Martos-Rus, C., Katz‐Greenberg, G., Zhao, L., Serrano, E., Whitaker‐Menezes, D., Domingo‐Vidal, M., Roche, M. E., Ramaswamy, K., Hooper, D. C., Falkner, B. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82685-4 · Cited by 30

Pro-inflammatory cytokines and leukocyte oxidative burst in chronic kidney disease: culprits or innocent bystanders?

Neirynck, N., Glorieux, G., Schepers, E., Dhondt, A., Verbeke, F., & Vanholder, R. C. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu409 · Cited by 30

Is Lipid Control Necessary in Hemodialysis Patients?

Cheung, A. K. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04780709 · Cited by 30

Nonextracorporeal Methods for Decreasing Uremic Solute Concentration: A Future Way To Go?

Meijers, B. K. I., Glorieux, G., Poesen, R., & Bakker, S. J. L. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.02.012 · Cited by 30

Relationship between oxidative stress and extrinsic coagulation pathway in haemodialyzed patients

Pawlak, K., Borawski, J., Naumnik, B., & Myśliwiec, M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00241-x · Cited by 30

Middle molecules and small-molecular-weight proteins in ESRD: properties and strategies for their removal

Clark, W. R., & Winchester, J. F. (2003) · Advances in Renal Replacement Therapy · doi:10.1053/j.arrt.2003.11.004 · Cited by 30

Low glomerular filtration rate and risk of myocardial infarction: A systematic review and meta-analysis

Vashistha, V., Lee, M., Wu, Y., Kaur, S., & Ovbiagele, B. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.175 · Cited by 29

Vascular disease and chronic renal failure: new insights.

Nanayakkara, P. W. B., & Gaillard, S. (2010) · PubMed · Cited by 29

Indoxyl Sulfate and p-Cresyl Sulfate in Chronic Kidney Disease. Could These Toxins Modulate the Antioxidant Nrf2-Keap1 Pathway?

Stockler‐Pinto, M. B., Fouque, D. P., Soulage, C. O., Croze, M. L., & Mafra, D. (2014) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.11.006 · Cited by 29

The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease

Chin, L., Hsu, Y., Hsu, S.-C., Chen, Y., Chang, Y., Huang, S., Tsai, C., & Lin, C. (2017) · Oncotarget · doi:10.18632/oncotarget.22964 · Cited by 31

Indoxyl sulfate reduces Ito,f by activating ROS/MAPK and NF-κB signaling pathways

Yang, J., Li, H., Zhang, C., & Zhou, Y. (2022) · JCI Insight · doi:10.1172/jci.insight.145475 · Cited by 28

Oxidative stress in uremia

Himmelfarb, J., & Hakim, R. M. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200311000-00004 · Cited by 189

POOR NUTRITIONAL STATUS AND INFLAMMATION: Linking Oxidative Stress and Inflammation in Kidney Disease: Which is the Chicken and Which is the Egg?

Himmelfarb, J. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17605.x · Cited by 139

Relevance of Oxidative Pathways in the Pathophysiology of Chronic Kidney Disease

Himmelfarb, J. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.005 · Cited by 81

Evolution of Oxidative Stress and Inflammation During Hemodialysis and Their Contribution to Cardiovascular Disease

Wratten, M. L., Galaris, D., Tetta, C., & Sevanian, A. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602762197470 · Cited by 41

Oxidative Stress in Hemodialysis

Himmelfarb, J. (2008) · KARGER eBooks · doi:10.1159/000130658 · Cited by 104